The Effect of Stemcell Treatment on Nephrotoxicity Developing After Cyclophosphamide Treatment

20260 citationsJournal Articlegold Open Access

Authors

Muzaffer Çaydere · Ministry of Health

Aytaj Jafarzade · Liv Hospital

Feyza Bayrakdar Çağlayan · Yüksek İhtisas Üniversitesi

Elvan Anadol · Gazi University

Durmuş Burgucu · Cleveland Cord Blood Center

Canan Yılmaz · Gazi University

Semih Ergişi ·

Abstract

In light of the current information, human Umbilical Cord Mesenchymal Stem Cell (hUC-MCS) has been demonstrated to reduce the nephrotoxicity caused by cyclophosphamide given for cytotoxic purposes on the kidney and exhibit induced renal regeneration. Our findings create new hope for the use of stem cell therapies in the field of kidney diseases.

Topics & Keywords

Chemotherapy-induced organ toxicity mitigation Mesenchymal stem cell research Renal and related cancers

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Dose-Response

Volume 24, Issue 1, pp. 15593258261437450-15593258261437450

DOI: 10.1177/15593258261437450

Field-Weighted Citation Impact: 0.00